Market Research Logo

Immunoassay - Global Market Outlook (2015-2022)

Immunoassay - Global Market Outlook (2015-2022)

According to Stratistics MRC, the global immunoassay market is estimated at $16.35 billion in 2015 and is expected to grow at a CAGR of 10.9% to reach $33.72 billion by 2022. Technological advancements and increasing geriatric population worldwide are some of the key factors fuelling the market growth. Increasing incidences of infectious & chronic diseases, demand for non-invasive diagnostic techniques, broad usage of immunoassays in oncology, growing need of reagents and speed, cost effectiveness & accuracy of immunoassay are additional drivers playing a key role in the growth of immunoassay market. However, execution of excise duty by the U.S. government and low detection limit are the factors limiting the market growth. Expansion of pharmaceutical and biotechnology industries in emerging regions such as Asia Pacific acts as opportunity for immunoassay market.

In 2015, Enzyme-Linked Immunosorbent Assay (ELISA) and Enzyme-linked ImmunoSpot (ELISPOT) assay dominated the global immunoassay technology market due to their high sensitivity and long term presence in the market. Oncology segment is witnessing a significant growth driven by the high incidence of cancer diseases. North America is anticipated to be the largest market for immunoassay, whereas Asia Pacific and MEA are projected to grow at a faster pace. The aging US population is supporting the market demand, since the requirement of these medical devices is higher in the elderly population.
The technological advancements, rising investments in pharmaceutical and biotechnology sector by government and corporate sector and rapidly growing healthcare market in emerging countries such as China and India are the factors favouring the market growth in this region.

Some of the key players in the global immunoassay market include Roche Diagnostics Limited, Thermo Fisher Scientific, Inc, Danaher Corporation, Siemens Healthcare, Becton, Dickinson And Company, Abbott Laboratories, Inc, Luminex Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Biomérieux SA, Ortho-Clinical Diagnostics, Inc., Alere, Inc., Qiagen NV, Meridian Life Science, Inc and Syntron Bioresearch, Inc.

Products & Services Covered:
Software and Services
Analyzers
Purchase Modes Analysers
Analyser Type
Reagents & KITS
Radioimmunoassay (RIA)
Western Blot
Polymerase Chain Reaction (PCR)
Enzyme-Linked Immunospot (ELISPOT)
Rapid Tests
Enzyme-Linked Immunosorbent Assay (ELISA) Reagents

Technologies Covered:
Radio Immunoassays (RIA)
Nephelometric Immunoassay
Western Blot
Fluorescence Immunoassay
Enzyme-Linked Immunosorbent Assay (ELISA)
Rapid Tests
Polymerase Chain Reaction (PCR)
Chemiluminescence Immunoassay
Enzyme-linked ImmunoSpot (ELISPOT) Assay

End Users Covered:
Pharma & Biotech Firms
Blood Banks
Hospitals
Clinical Laboratories
Academic Research Centers
Contract Research Organizations
Other End Users

Applications Covered:
Cardiology
Autoimmune Disorders
Oncology
Toxicology
Infectious Diseases
Neonatal Screening
Hematology and Blood Screening
Endocrinology
Bone and Mineral Disorders
Other Applications

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancement


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 End User Analysis
3.9 Application Analysis
3.10 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Immunoassay Market, By Product & Service
5.1 Introduction
5.2 Software and Services
5.3 Analyzers
5.3.1 Purchase Modes Analysers
5.3.1.1 Outright Purchase
5.3.1.2 Reagent Rental Purchase
5.3.2 Analyser Type
5.3.2.1 Open NDED Systems
5.3.2.2 Closed NDED Systems
5.4 Reagents & KITS
5.4.1 Radioimmunoassay (RIA)
5.4.2 Western Blot
5.4.3 Polymerase Chain Reaction (PCR)
5.4.4 Enzyme-Linked Immunospot (ELISPOT)
5.4.5 Rapid Tests
5.4.6 Enzyme-Linked Immunosorbent Assay (ELISA) Reagents
6 Global Immunoassay Market, By Technology
6.1 Introduction
6.2 Radio Immunoassays (RIA)
6.3 Nephelometric Immunoassay
6.4 Western Blot
6.5 Fluorescence Immunoassay
6.6 Enzyme-Linked Immunosorbent Assay (ELISA)
6.7 Rapid Tests
6.8 Polymerase Chain Reaction (PCR)
6.9 Chemiluminescence Immunoassay
6.10 Enzyme-linked ImmunoSpot (ELISPOT) Assay
7 Global Immunoassay Market, By End User
7.1 Introduction
7.2 Pharma & Biotech Firms
7.3 Blood Banks
7.4 Hospitals
7.5 Clinical Laboratories
7.6 Academic Research Centers
7.7 Contract Research Organizations
7.8 Other End Users
8 Global Immunoassay Market, By Application
8.1 Introduction
8.2 Cardiology
8.3 Autoimmune Disorders
8.4 Oncology
8.5 Toxicology
8.6 Infectious Diseases
8.7 Neonatal Screening
8.8 Hematology and Blood Screening
8.9 Endocrinology
8.10 Bone and Mineral Disorders
8.11 Other Applications
9 Global Immunoassay Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Roche Diagnostics Limited
11.2 Thermo Fisher Scientific, Inc
11.3 Danaher Corporation
11.4 Siemens Healthcare
11.5 Becton, Dickinson And Company
11.6 Abbott Laboratories, Inc
11.7 Luminex Corporation
11.8 Bio-Rad Laboratories, Inc.
11.9 Sysmex Corporation
11.10 Biomérieux SA
11.11 Ortho-Clinical Diagnostics, Inc.
11.12 Alere, Inc.
11.13 Qiagen NV
11.14 Meridian Life Science, Inc
11.15 Syntron Bioresearch, Inc.
List of Tables
Table 1 Global Immunoassay Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
Table 3 Global Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
Table 4 Global Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
Table 5 Global Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
Table 6 Global Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
Table 7 Global Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
Table 8 Global Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
Table 9 Global Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
Table 10 Global Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
Table 11 Global Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
Table 12 Global Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
Table 13 Global Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 14 Global Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 15 Global Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
Table 16 Global Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 17 Global Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
Table 18 Global Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
Table 19 Global Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
Table 20 Global Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
Table 21 Global Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 22 Global Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
Table 23 Global Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
Table 24 Global Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 25 Global Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 26 Global Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
Table 27 Global Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
Table 28 Global Immunoassay Market Outlook, By End User (2013-2022) ($MN)
Table 29 Global Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
Table 30 Global Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
Table 31 Global Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
Table 32 Global Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
Table 33 Global Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
Table 34 Global Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 35 Global Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
Table 36 Global Immunoassay Market Outlook, By Application (2013-2022) ($MN)
Table 37 Global Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
Table 38 Global Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 39 Global Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
Table 40 Global Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
Table 41 Global Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 42 Global Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
Table 43 Global Immunoassay Market Outlook, By Hematology and Blood Screening (2013-2022) ($MN)
Table 44 Global Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 45 Global Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
Table 46 Global Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)
Table 47 North America Immunoassay Market Outlook, By Country (2013-2022) ($MN)
Table 48 North America Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
Table 49 North America Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
Table 50 North America Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
Table 51 North America Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
Table 52 North America Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
Table 53 North America Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
Table 54 North America Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
Table 55 North America Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
Table 56 North America Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
Table 57 North America Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
Table 58 North America Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
Table 59 North America Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 60 North America Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 61 North America Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
Table 62 North America Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 63 North America Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
Table 64 North America Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
Table 65 North America Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
Table 66 North America Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
Table 67 North America Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 68 North America Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
Table 69 North America Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
Table 70 North America Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 71 North America Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 72 North America Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
Table 73 North America Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
Table 74 North America Immunoassay Market Outlook, By End User (2013-2022) ($MN)
Table 75 North America Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
Table 76 North America Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
Table 77 North America Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
Table 78 North America Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
Table 79 North America Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
Table 80 North America Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 81 North America Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
Table 82 North America Immunoassay Market Outlook, By Application (2013-2022) ($MN)
Table 83 North America Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
Table 84 North America Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 85 North America Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
Table 86 North America Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
Table 87 North America Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 88 North America Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
Table 89 North America Immunoassay Market Outlook, By Hematology and Blood Screening (2013-2022) ($MN)
Table 90 North America Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 91 North America Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
Table 92 North America Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)
Table 93 Europe Immunoassay Market Outlook, By Country (2013-2022) ($MN)
Table 94 Europe Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
Table 95 Europe Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
Table 96 Europe Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
Table 97 Europe Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
Table 98 Europe Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
Table 99 Europe Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
Table 100 Europe Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
Table 101 Europe Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
Table 102 Europe Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
Table 103 Europe Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
Table 104 Europe Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
Table 105 Europe Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 106 Europe Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 107 Europe Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
Table 108 Europe Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 109 Europe Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
Table 110 Europe Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
Table 111 Europe Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
Table 112 Europe Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
Table 113 Europe Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 114 Europe Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
Table 115 Europe Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
Table 116 Europe Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 117 Europe Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 118 Europe Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
Table 119 Europe Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
Table 120 Europe Immunoassay Market Outlook, By End User (2013-2022) ($MN)
Table 121 Europe Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
Table 122 Europe Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
Table 123 Europe Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
Table 124 Europe Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
Table 125 Europe Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
Table 126 Europe Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 127 Europe Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
Table 128 Europe Immunoassay Market Outlook, By Application (2013-2022) ($MN)
Table 129 Europe Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
Table 130 Europe Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 131 Europe Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
Table 132 Europe Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
Table 133 Europe Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 134 Europe Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
Table 135 Europe Immunoassay Market Outlook, By Hematology and Blood Screening (2013-2022) ($MN)
Table 136 Europe Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 137 Europe Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
Table 138 Europe Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)
Table 139 Asia Pacific Immunoassay Market Outlook, By Country (2013-2022) ($MN)
Table 140 Asia Pacific Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
Table 141 Asia Pacific Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
Table 142 Asia Pacific Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
Table 143 Asia Pacific Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
Table 144 Asia Pacific Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
Table 145 Asia Pacific Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
Table 146 Asia Pacific Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
Table 147 Asia Pacific Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
Table 148 Asia Pacific Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
Table 149 Asia Pacific Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
Table 150 Asia Pacific Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
Table 151 Asia Pacific Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 152 Asia Pacific Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 153 Asia Pacific Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
Table 154 Asia Pacific Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 155 Asia Pacific Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
Table 156 Asia Pacific Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
Table 157 Asia Pacific Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
Table 158 Asia Pacific Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
Table 159 Asia Pacific Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 160 Asia Pacific Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
Table 161 Asia Pacific Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
Table 162 Asia Pacific Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 163 Asia Pacific Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 164 Asia Pacific Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
Table 165 Asia Pacific Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
Table 166 Asia Pacific Immunoassay Market Outlook, By End User (2013-2022) ($MN)
Table 167 Asia Pacific Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
Table 168 Asia Pacific Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
Table 169 Asia Pacific Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
Table 170 Asia Pacific Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
Table 171 Asia Pacific Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
Table 172 Asia Pacific Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 173 Asia Pacific Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
Table 174 Asia Pacific Immunoassay Market Outlook, By Application (2013-2022) ($MN)
Table 175 Asia Pacific Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
Table 176 Asia Pacific Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 177 Asia Pacific Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
Table 178 Asia Pacific Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
Table 179 Asia Pacific Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 180 Asia Pacific Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
Table 181 Asia Pacific Immunoassay Market Outlook, By Hematology and Blood Screening (2013-2022) ($MN)
Table 182 Asia Pacific Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 183 Asia Pacific Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
Table 184 Asia Pacific Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)
Table 185 RoW Immunoassay Market Outlook, By Country (2013-2022) ($MN)
Table 186 RoW Immunoassay Market Outlook, By Product & Service (2013-2022) ($MN)
Table 187 RoW Immunoassay Market Outlook, By Software and Services (2013-2022) ($MN)
Table 188 RoW Immunoassay Market Outlook, By Analyzers (2013-2022) ($MN)
Table 189 RoW Immunoassay Market Outlook, By Purchase Modes Analysers (2013-2022) ($MN)
Table 190 RoW Immunoassay Market Outlook, By Outright Purchase (2013-2022) ($MN)
Table 191 RoW Immunoassay Market Outlook, By Reagent Rental Purchase (2013-2022) ($MN)
Table 192 RoW Immunoassay Market Outlook, By Analyser Type (2013-2022) ($MN)
Table 193 RoW Immunoassay Market Outlook, By Open NDED Systems (2013-2022) ($MN)
Table 194 RoW Immunoassay Market Outlook, By Closed NDED Systems (2013-2022) ($MN)
Table 195 RoW Immunoassay Market Outlook, By Reagents & KITS (2013-2022) ($MN)
Table 196 RoW Immunoassay Market Outlook, By Radioimmunoassay (RIA) (2013-2022) ($MN)
Table 197 RoW Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 198 RoW Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 199 RoW Immunoassay Market Outlook, By Enzyme-Linked Immunospot (ELISPOT) (2013-2022) ($MN)
Table 200 RoW Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 201 RoW Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) Reagents (2013-2022) ($MN)
Table 202 RoW Immunoassay Market Outlook, By Technology (2013-2022) ($MN)
Table 203 RoW Immunoassay Market Outlook, By Radio Immunoassays (RIA) (2013-2022) ($MN)
Table 204 RoW Immunoassay Market Outlook, By Nephelometric Immunoassay (2013-2022) ($MN)
Table 205 RoW Immunoassay Market Outlook, By Western Blot (2013-2022) ($MN)
Table 206 RoW Immunoassay Market Outlook, By Fluorescence Immunoassay (2013-2022) ($MN)
Table 207 RoW Immunoassay Market Outlook, By Enzyme-Linked Immunosorbent Assay (ELISA) (2013-2022) ($MN)
Table 208 RoW Immunoassay Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 209 RoW Immunoassay Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 210 RoW Immunoassay Market Outlook, By Chemiluminescence Immunoassay (2013-2022) ($MN)
Table 211 RoW Immunoassay Market Outlook, By Enzyme-linked ImmunoSpot (ELISPOT) Assay (2013-2022) ($MN)
Table 212 RoW Immunoassay Market Outlook, By End User (2013-2022) ($MN)
Table 213 RoW Immunoassay Market Outlook, By Pharma & Biotech Firms (2013-2022) ($MN)
Table 214 RoW Immunoassay Market Outlook, By Blood Banks (2013-2022) ($MN)
Table 215 RoW Immunoassay Market Outlook, By Hospitals (2013-2022) ($MN)
Table 216 RoW Immunoassay Market Outlook, By Clinical Laboratories (2013-2022) ($MN)
Table 217 RoW Immunoassay Market Outlook, By Academic Research Centers (2013-2022) ($MN)
Table 218 RoW Immunoassay Market Outlook, By Contract Research Organizations (2013-2022) ($MN)
Table 219 RoW Immunoassay Market Outlook, By Other End Users (2013-2022) ($MN)
Table 220 RoW Immunoassay Market Outlook, By Application (2013-2022) ($MN)
Table 221 RoW Immunoassay Market Outlook, By Cardiology (2013-2022) ($MN)
Table 222 RoW Immunoassay Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 223 RoW Immunoassay Market Outlook, By Oncology (2013-2022) ($MN)
Table 224 RoW Immunoassay Market Outlook, By Toxicology (2013-2022) ($MN)
Table 225 RoW Immunoassay Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 226 RoW Immunoassay Market Outlook, By Neonatal Screening (2013-2022) ($MN)
Table 227 RoW Immunoassay Market Outlook, By Hematology and Blood Screening (2013-2022) ($MN)
Table 228 RoW Immunoassay Market Outlook, By Endocrinology (2013-2022) ($MN)
Table 229 RoW Immunoassay Market Outlook, By Bone and Mineral Disorders (2013-2022) ($MN)
Table 230 RoW Immunoassay Market Outlook, By Other Applications (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report